295 related articles for article (PubMed ID: 2863153)
1. Interaction of SCH 23390, a D-1-selective antagonist, with the anterior pituitary D-2 receptors and prolactin secretion in the rat.
Apud JA; Masotto C; Ongini E; Racagni G
Eur J Pharmacol; 1985 Jun; 112(2):187-93. PubMed ID: 2863153
[TBL] [Abstract][Full Text] [Related]
2. Absence of [3H]SCH 23390 specific binding sites in anterior pituitary: dissociation from effects on prolactin secretion.
Rovescalli AC; Brunello N; Monopoli A; Ongini E; Racagni G
Eur J Pharmacol; 1987 Mar; 135(2):129-36. PubMed ID: 3556197
[TBL] [Abstract][Full Text] [Related]
3. Effects of repeated tiapride administration on anterior pituitary dopamine receptors and prolactin release in the rat.
Apud JA; Masotto C; Monopoli A; Ongini E; Rovescalli AC; Racagni G
Pharmacol Res Commun; 1987 Feb; 19(2):119-29. PubMed ID: 3588649
[TBL] [Abstract][Full Text] [Related]
4. Identification of a D1 dopamine receptor, not linked to adenylate cyclase, on lactotroph cells.
Schoors DF; Vauquelin GP; De Vos H; Smets G; Velkeniers B; Vanhaelst L; Dupont AG
Br J Pharmacol; 1991 Aug; 103(4):1928-34. PubMed ID: 1833020
[TBL] [Abstract][Full Text] [Related]
5. Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices.
Tedford CE; Crosby G; Iorio LC; Chipkin RE
Eur J Pharmacol; 1992 Feb; 211(2):169-76. PubMed ID: 1535318
[TBL] [Abstract][Full Text] [Related]
6. SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors.
Boyce S; Kelly E; Davis A; Fleminger S; Jenner P; Marsden CD
Biochem Pharmacol; 1985 May; 34(10):1665-9. PubMed ID: 2988552
[TBL] [Abstract][Full Text] [Related]
7. Effect of amantadine on prolactin secretion, pituitary DNA synthesis and 3H-spiperone binding in male estrogen-treated rats.
Krawczyk Z; Lyson K; Stawowy A; Pisarek H; Stepien H
Neuroendocrinology; 1990 Jun; 51(6):632-6. PubMed ID: 2141919
[TBL] [Abstract][Full Text] [Related]
8. Elevation of plasma prolactin concentrations by intravenous SCH 23390 and SKF 38393 in conscious rats.
Tanimoto K; Tamminga CA; Chase TN
Eur J Pharmacol; 1987 Dec; 144(2):147-51. PubMed ID: 3325296
[TBL] [Abstract][Full Text] [Related]
9. [The inhibition of dopamine D1 and D2 receptors in human putamen by antipsychotic drugs].
Kobayashi T; Shimizu H; Toru M
Yakubutsu Seishin Kodo; 1990 Jun; 10(2):331-4. PubMed ID: 1979198
[TBL] [Abstract][Full Text] [Related]
10. SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems.
Iorio LC; Barnett A; Leitz FH; Houser VP; Korduba CA
J Pharmacol Exp Ther; 1983 Aug; 226(2):462-8. PubMed ID: 6135795
[TBL] [Abstract][Full Text] [Related]
11. Sedation and sleep induced by high doses of apomorphine after blockade of D-1 receptors by SCH 23390.
Gessa GL; Porceddu ML; Collu M; Mereu G; Serra M; Ongini E; Biggio G
Eur J Pharmacol; 1985 Feb; 109(2):269-74. PubMed ID: 2859998
[TBL] [Abstract][Full Text] [Related]
12. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
[TBL] [Abstract][Full Text] [Related]
13. Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat.
Swerdlow NR; Keith VA; Braff DL; Geyer MA
J Pharmacol Exp Ther; 1991 Feb; 256(2):530-6. PubMed ID: 1825226
[TBL] [Abstract][Full Text] [Related]
14. Functional evidence for selective dopamine D-1 receptor blockade by SCH 23390.
Hyttel J
Neuropharmacology; 1984 Dec; 23(12A):1395-401. PubMed ID: 6152023
[TBL] [Abstract][Full Text] [Related]
15. Involvement of postnatal gonads in the maturation of dopaminergic regulation of prolactin secretion in female rats.
Watanobe H; Takebe K
Endocrinology; 1987 Jun; 120(6):2212-9. PubMed ID: 3569131
[TBL] [Abstract][Full Text] [Related]
16. Effects of chronic treatment with selective and nonselective antagonists on the subtypes of dopamine receptors.
McGonigle P; Boyson SJ; Reuter S; Molinoff PB
Synapse; 1989; 3(1):74-82. PubMed ID: 2521960
[TBL] [Abstract][Full Text] [Related]
17. D-2 dopamine receptor activation reduces free [3H]arachidonate release induced by hypophysiotropic peptides in anterior pituitary cells.
Canonico PL
Endocrinology; 1989 Sep; 125(3):1180-6. PubMed ID: 2527149
[TBL] [Abstract][Full Text] [Related]
18. Dopamine receptor reappearance after irreversible receptor blockade: effect of chronic estradiol treatment of ovariectomized rats.
Lévesque D; Di Paolo T
Mol Pharmacol; 1991 May; 39(5):659-65. PubMed ID: 1674586
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms involved in the prolactin-releasing effect of benserazide.
Parati EA; Penalva A; Bondiolotti GP; Parenti M; Locatelli V; Picotti GB; Cocchi D; Müller EE
Eur J Pharmacol; 1984 Jun; 101(3-4):215-21. PubMed ID: 6468496
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.
Chipkin RE; Iorio LC; Coffin VL; McQuade RD; Berger JG; Barnett A
J Pharmacol Exp Ther; 1988 Dec; 247(3):1093-102. PubMed ID: 2905002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
